APIs, Excipients, and Manufacturing eBook
Read the article:
Containing and Enhancing Potent Particles with Micronization
Read the ebook:
Pharmaceutical Technology APIs, Excipients, and Manufacturing eBook
Containing and Enhancing Potent Particles with Micronization
A multilayered processing approach ensures safe handling and content uniformity of highly potent APIs.
KWANCHAIFT - STOCK.ADOBE.COM
Micronization is an important tool for developing new drugs, its primary advantage being that it is scalable from the early stages of development through to commercial volumes. The micronization process is both well-understood and cost-effective.
With the increased number of potent drugs in development, having the capabilities to handle and process them is becoming imperative. Development partners with the specialized expertise and infrastructure required to handle potent APIs play a key role in the supply chain of next generation medicines.
Read this article in Pharmaceutical Technology’s October 2021 APIs, Excipients, and Manufacturing eBook.
About the Author
Andy Maitland is operations and supply chain director, Catalent.
Article Details
Pharmaceutical Technology
eBook: APIs, Excipients, and Manufacturing
October 2021
Pages: 30–35
Citation
When referring to this article, please cite it as A. Maitland, “Containing and Enhancing Potent Particles with Micronization,” Pharmaceutical Technology APIs, Excipients, and Manufacturing eBook (October 2021).
Related Content
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023Podcast
In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
